Interesting question but please keep in mind that Pfizer is not a one stock play. Take an article entitled These Are the Most Promising Experimental Cancer Drugs (easily viable on the web at link provided). In the article various ongoing cancer immunotherapies or treatments are discussed from companies from MRK, BMY, JUNO, KITE, CELG, NVS, LLY, and PFE.
There are two interesting points on PFE in the short caption, one that could have direct application to Elite's launch of SequestOXY. Although Elite will likely not be the first company to launch an ART pain killer it could be close enough. Here is the caption on PFE:
Breast cancer treatments—Pfizer/Eli Lilly/Novartis
Pfizer PFE 0.17% breast cancer treatment Ibrance burst onto the scene in early 2015 and proceeded to dominate in a new therapeutic arena called cyclin-dependent kinase (CDK) 4 and 6 inhibitors. The treatment has proven extremely effective in the hardest-to-treat breast cancers and is on the verge of achieving blockbuster drug status (meaning annual sales of $1 billion or more).
Major competitors like Eli Lilly LLY -0.64% and Novartis are in the process of making competing therapies (Lilly’s abemaciclib and Novartis’ ribociclib). But according to Loncar, Pfizer will continue to benefit from a distinct first-to-market advantage barring spectacular results from its rivals.
“I think that Lilly’s abemaciclib data is still a hair underneath Pfizer’s,” he said, “so I think when you add that on top of the fact that Pfizer’s already out there and selling, I have confidence that they’re still going to dominate that market.”
“Now, that may change when we see Novartis’ data at some future date,” he added. “But I think that Pfizer still has a competitive edge….”
I glanced at several other articles on Ibrance treatment which could range in cost from $9K to $10K per month but I need further research as to expected number of months needed for a complete treatment and success expectations. One point relevant to the question of why PFE stock price is rising and one relevant to Elite's future drug and is highlighted above.
For interest and possible use by others. I am doing this DD for help my sister who just two weeks ago was diagnosed to have breast cancer with cancer contained (not spreading). Problem is that due to age and previous stroke the risk of life from normal surgical, chemo, or radiation are ruled out. Any additional info please PM me.
Note: I will no longer post on Elite absent specific DD content for my posts.
News 
Market Data 
Discover 
